Quince Therapeutics Inc (QNCX) Prezzo delle Azioni, Quotazione, Notizie e Storico | Benzinga

Quince Therapeutics Inc (QNCX) Prezzo delle Azioni, Quotazione, Notizie e Storico

QNCXNASDAQ

Trade with Public

Trade with Public

$30.50

-1.23-3.88%

Ult. Agg.: Oct 9, 9:27 AM

$30.50

-1.23-3.88%

PanoramicaNotizie Previsioni utili Eventi Obiettivi di prezzo Dati finanziari Sentiment Azionariato Confronta Rapporto azionario

© 2026 Benzinga | All Rights Reserved

Statistiche Chiave

Aperto

-

Chiuso

-

Volume / Media

0 / 28.71K

Intervallo giornaliero

- - -

Intervallo a 52 settimane

15.10 - 18.20K

Capitalizzazione di mercato

$31.02M

Rapporto P/E

-

Rendimento del dividendo

-

Exchange

NASDAQ

RSI

-

Vendite allo scoperto

-

Periodo di copertura

2.67

Notizie Recenti di Quince Therapeutics Inc

This Ares Management Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts initiated coverage: ARES Overweight, $150; MGEE Neutral, $76; TTRX Buy, $24; QNCX Buy, $70; EFSC Buy, $70.

Avi Kapoor

Dow Jumps Over 1,300 Points; Delta Air Lines Shares Gain After Q1 Results

US stocks rose, Dow up 2.85%, Nasdaq up 3.33%, S&P 500 up 2.54%. Consumer discretionary shares up 3.9%, energy stocks down 6.6%.

Avi Kapoor

Why Levi Strauss Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

Levi Strauss (LEVI) reported strong Q1 2026 results, raising revenue & earnings guidance. Other pre-market gainers include QNCX, VSME, UCAR, IPW, JEM, AZI, GPUS, AXTI, IPX.

Avi Kapoor

What Sparked Quince Therapeutics (QNCX) Stock To Rise 53% After Hours

Quince Therapeutics shares surged 53% after hours Thursday following the engagement of LifeSci Capital as financial advisor amid restructuring and strategic plans.

Mohd Haider

Quince Therapeutics Stock Plunges As Filing Shows Reverse Merger Plans, Bankruptcy Risks

Quince Therapeutics stock is trading sharply lower Thursday after the biotech company followed up Wednesday's rally with a Form 8-K that underscores how precarious its situation is.

Henry Khederian

Dati finanziari

Trimestrale

Annuale

Nome

Ricavi Variazioni
Lordo Variazioni
EBITDA Variazioni
EBIT Variazioni
Utili Variazioni

Trend degli analisti

2

giu

1

lug

1

ago

1

set

1

ott

Acquistare

Tenere

Vendere

Vendere fortemente

Valutazione degli analisti

4.4

Acquistare

Acquistare fortemente

Acquistare

Tenere

Vendere

Vendere fortemente